The Clinical Outcomes of Acute Myocarditis in Pediatric Population: A Prospective Study
Article Sidebar
Main Article Content
Abstract
Background: Myocarditis, a serious complication of acute viral infections, is a significant concern in pediatric healthcare. Often underdiagnosed due to its subtle symptoms like cough and easy fatigability, myocarditis can lead to severe cardiac complications.
Objectives: The primary objective of this study was to examine the outcomes of acute myocarditis in children who received early diagnosis and management. The study focused on identifying factors influencing these outcomes, rather than comparing different treatment methods.
Methods: This prospective study involved 118 pediatric patients (age < 16 years) admitted with acute myocarditis to the Pediatric Cardiology Ward at Lady Reading Hospital. Data were collected using a specialized proforma with informed consent. Comprehensive monitoring included echocardiography for assessing left ventricular function, ECG for arrhythmia detection, and cardiac enzyme levels. Patients were treated with a standard management plan, including immunosuppressive therapy, diuretics, and inotropic support. Follow-up was conducted for an average of six months.
Results: The age distribution was as follows: 70 patients in Group-A (below 4 years), 35 in Group-B (5-10 years), and 13 in Group-C (10-16 years). The gender ratio was 53 males to 65 females. Ejection fractions were: 15-20% in 40 patients, 20-25% in 44 patients, and 26-35% in 34 patients. Left Ventricular End-Diastolic Diameter (LVEDD) showed 49 patients in Grade 1, 45 in Grade 2, and 24 in Grade 3. Improvements were observed in 37 patients (31.3%) with normal ventricular functions, 32 (27.1%) with mild dysfunction, and 29 (24.5%) with moderate dysfunction. 20 patients (16.9%) showed no improvement, and complications included LV clot (11%), stroke (2.5%), arrhythmias (1.7%), and mortality (5.9%).
Conclusion: Timely diagnosis and appropriate management are crucial for improving outcomes in children with acute myocarditis. Delayed management can lead to severe complications including dilated cardiomyopathy, cardiac thrombi, stroke, arrhythmias, and mortality.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Leonard EG. Viral myocarditis. Pediatr Infect Dis J. 2004;23(7):665–6.
Webber SA, Boyle GJ, Jaffe R, Pickering RM, Beerman LB, Fricker FJ. Role of right ventricular endomyocardial biopsy in infants and children with suspected or possible myocarditis. Br Heart J. 1994;72(4):360–3.
May LJ, Patton DJ, Fruitman DS. The evolving approach to pediatric myocarditis: a review of the current literature. Cardiol Young. 2011;21(3):241–51.
Chan KY, Iwahara M, Benson LN, Wilson GJ, Freedom RM. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. J Am Coll Cardiol. 1991;17(2):458–60.
Kleinert S, Weintraub RG, Wilkinson JL, Chow CW. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant. 1997;16(12):1248-1254.
Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333(5):269-275. doi:10.1056/NEJM199508033330501
Camargo PR, Snitcowsky R, da Luz PL, et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol. 1995;16(2):61-68. doi:10.1007/BF00796819
Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child. 2004;89(6):580-584. doi:10.1136/adc.2003.034686
Lu C, Qin F, Yan Y, Liu T, Li J, Chen H. Immunosuppressive treatment for myocarditis: a meta-analysis of randomized controlled trials. J Cardiovasc Med (Hagerstown). 2016;17(8):631–639
Chen HS, Wang W, Wu SN, Liu JP. Corticosteroids for viral myocarditis. Cochrane Database Syst Rev. 2013;10:CD00447.
Klugman D, Berger JT, Sable CA, He J, Khandelwal SG, Slonim AD. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol. 2010;31(2):222–8.
Koestenberger M, Nagel B, Ravekes W, et al. Reference values and calculation of z-scores of echocardiographic measurements of the normal pediatric right ventricle [published correction appears in Am J Cardiol. 2016 Jan 15;117(2):317]. Am J Cardiol. 2014;114(10):1590-1598. doi:10.1016/j.amjcard.2014.08.028
Tissot C, Singh Y, Sekarski N. Echocardiographic Evaluation of Ventricular Function-For the Neonatologist and Pediatric Intensivist. Front Pediatr. 2018;6:79. Published 2018 Apr 4. doi:10.3389/fped.2018.00079
Chang YJ, Hsiao HJ, Hsia SH, et al. Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis. PLoS One. 2019;14(3):e0214087. Published 2019 Mar 20. doi:10.1371/journal.pone.0214087
Burch M. Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence. Heart. 2004;90(10):1103-1104. doi:10.1136/hrt.2004.034082
McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P, Mann DL, Feldman AM. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001;103(18):2254–9.
Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, Baker AL, Perez-Atayde AR, Newburger JW. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. 1994;89(1):252–7.
Robinson J, Hartling L, Vandermeer B, Klassen TP. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev 2015; (5): CD004370. https://doi.org/10.1002/14651858.CD004370.pub3.
Prasad AN, Chaudhary S. Intravenous immunoglobulin in children with acute myocarditis and/or early dilated cardiomyopathy. Indian Pediatr. 2014;51(7):583–4.
Yu DQ, Wang Y, Ma GZ, Xu RH, Cai ZX, Ni CM, Chen P, Zhu ZD. Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: a retrospective study. Exp Ther Med. 2014;7(1):97–102.
Tsai YG, Ou TY, Wang CC, Tsai MC, Yuh YS, Hwang B. Intravenous gamma-globulin therapy in myocarditis complicated with complete heart block: report of one case. Acta Paediatr Taiwan. 2001;42(5):311–3.
Aziz KU, Patel N, Sadullah T, Tasneem H, Thawerani H, Talpur S. Acute viral myocarditis: role of immunosuppression: a prospective randomised study. Cardiol Young. 2010;20(5):509–516.